Personal Cfo Solutions, LLC Bicycle Therapeutics PLC Transaction History

Personal Cfo Solutions, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$12.95 - $46.99 $96,542 - $350,310	-7,455 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$40.12 - $59.5 $481 - $714	-12 Reduced 0.16%	7,455 $327,000
Q4 2021 Feb 11, 2022	SELL	$41.7 - $61.14 $3,794 - $5,563	-91 Reduced 1.2%	7,467 $455,000
Q3 2021 Nov 18, 2021	BUY	$27.95 - $44.24 $7,630 - $12,077	273 Added 3.75%	7,558 $314,000
Q2 2021 Jul 22, 2021	BUY	$27.0 - $32.28 $196,695 - $235,159	7,285 New	7,285 $221,000

111

40.8M

39.6K

24.6K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $436M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Personal Cfo Solutions, LLC with notifications on news.